| human | Q5 |
| P10283 | OpenAlex ID | A5037936416 |
| P496 | ORCID iD | 0000-0003-2604-5277 |
| P108 | employer | University of Virginia | Q213439 |
| P734 | family name | Lindner | Q4261994 |
| Lindner | Q4261994 | ||
| Lindner | Q4261994 | ||
| P101 | field of work | ultrasound | Q162564 |
| P735 | given name | Jonathan | Q1158394 |
| Jonathan | Q1158394 | ||
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | NZThesisProject | Q111645234 |
| Q99201420 | A Survey of CEUS Education in Sonographer Training Programs: The Well-Opacified and Delineated Road Less Travelled, and Ready to be Taken |
| Q92626798 | A neonatal nonhuman primate model of gestational Zika virus infection with evidence of microencephaly, seizures and cardiomyopathy |
| Q39767446 | A suggested roadmap for cardiovascular ultrasound research for the future |
| Q37293485 | ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. |
| Q34883156 | ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents |
| Q40784866 | Abnormal Regulation of Microvascular Tone in a Murine Model of Sickle Cell Disease Assessed by Contrast Ultrasound |
| Q30435895 | Abnormal skeletal muscle capillary recruitment during exercise in patients with type 2 diabetes mellitus and microvascular complications |
| Q36309437 | Activity restriction, impaired capillary function, and the development of insulin resistance in lean primates |
| Q30472825 | Albumin microbubble persistence during myocardial contrast echocardiography is associated with microvascular endothelial glycocalyx damage |
| Q51149855 | Anatomy and flow in normal and ischemic microvasculature based on a novel temporal fractal dimension analysis algorithm using contrast enhanced ultrasound. |
| Q104068872 | Arterial Thrombotic Complications of Tyrosine Kinase Inhibitors |
| Q91433063 | Assessment of Novel Antioxidant Therapy in Atherosclerosis by Contrast Ultrasound Molecular Imaging |
| Q30437120 | Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression |
| Q30443850 | Assessment of ischemia-induced microvascular remodeling using contrast-enhanced ultrasound vascular anatomic mapping |
| Q30309674 | Assessment of myocardial inflammation produced by experimental coronary occlusion and reperfusion with 99mTc-RP517, a new leukotriene B4 receptor antagonist that preferentially labels neutrophils in vivo |
| Q30469106 | Assessment of myocardial viability with two-dimensional echocardiography and magnetic resonance imaging |
| Q30304643 | Assessment of resting perfusion with myocardial contrast echocardiography: theoretical and practical considerations |
| Q38381108 | Augmentation of Muscle Blood Flow by Ultrasound Cavitation Is Mediated by ATP and Purinergic Signaling |
| Q92676874 | Augmentation of Tissue Perfusion in Patients With Peripheral Artery Disease Using Microbubble Cavitation |
| Q30386954 | Augmentation of limb perfusion and reversal of tissue ischemia produced by ultrasound-mediated microbubble cavitation. |
| Q30440033 | Automated quantification of the spatial extent of perfusion defects and viability on myocardial contrast echocardiography |
| Q43906459 | Automated, nonrigid alignment of clinical myocardial contrast echocardiography image sequences: comparison with manual alignment |
| Q30433437 | Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow |
| Q37658505 | Cardiovascular and systemic microvascular effects of anti-vascular endothelial growth factor therapy for cancer. |
| Q38187761 | Cardiovascular drug delivery with ultrasound and microbubbles |
| Q30434482 | Changes in myocardial blood volume over a wide range of coronary driving pressures: role of capillaries beyond the autoregulatory range |
| Q53080697 | Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update. |
| Q45889188 | Comparison of gene delivery techniques for therapeutic angiogenesis ultrasound-mediated destruction of carrier microbubbles versus direct intramuscular injection |
| Q79510358 | Contrast echocardiography |
| Q30310299 | Contrast echocardiography |
| Q100736614 | Contrast echocardiography: current status and future directions |
| Q40140132 | Contrast echocardiography: past, present, and...future? |
| Q84277561 | Contrast ultrasound molecular imaging: harnessing the power of bubbles |
| Q92003338 | Contrast-Enhanced Ultrasound to Detect Early Microvascular Changes in Skeletal Muscle after High-Dose Radiation Treatment |
| Q35353507 | Contrast-enhanced ultrasound assessment of impaired adipose tissue and muscle perfusion in insulin-resistant mice |
| Q91650673 | Contrast-enhanced ultrasound detects changes in microvascular blood flow in adults with sickle cell disease |
| Q92134436 | Coronary Microvascular Dysfunction by Myocardial Contrast Echocardiography in Nonelderly Patients Referred for Computed Tomographic Coronary Angiography |
| Q30308295 | Decrease in coronary blood flow reserve during hyperlipidemia is secondary to an increase in blood viscosity |
| Q30441174 | Deformable gas-filled microbubbles targeted to P-selectin |
| Q30306428 | Delayed onset of inflammation in protease-activated receptor-2-deficient mice |
| Q34287277 | Delivery of drugs with ultrasound |
| Q30470687 | Deoxygenated blood minimizes adherence of sonicated albumin microbubbles during cardioplegic arrest and after blood reperfusion: experimental and clinical observations with myocardial contrast echocardiography |
| Q30559110 | Detection of antecedent myocardial ischemia with multiselectin molecular imaging |
| Q30310623 | Detection of myocardial viability by contrast echocardiography in acute infarction predicts recovery of resting function and contractile reserve |
| Q30436057 | Detection of peripheral vascular stenosis by assessing skeletal muscle flow reserve |
| Q50995366 | Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography. |
| Q30468356 | Diagnostic value of echocardiography in suspected endocarditis. An evaluation based on the pretest probability of disease |
| Q30461411 | Dysregulated selectin expression and monocyte recruitment during ischemia-related vascular remodeling in diabetes mellitus |
| Q103758370 | ECHOCARDIOGRAPHIC MOLECULAR IMAGING OF THE EFFECT OF ANTI-CYTOKINE THERAPY FOR ATHEROSCLEROSIS |
| Q30276554 | Echocardiographic Ischemic Memory Imaging Through Complement-Mediated Vascular Adhesion of Phosphatidylserine-Containing Microbubbles |
| Q37625091 | Echocardiographic evaluation of the effects of stem cell therapy on perfusion and function in ischemic cardiomyopathy |
| Q33511096 | Echocardiographic particle image velocimetry: a novel technique for quantification of left ventricular blood vorticity pattern |
| Q30477838 | Effect of acoustic power on in vivo molecular imaging with targeted microbubbles: implications for low-mechanical index real-time imaging. |
| Q30437175 | Effect of microbubble exposure to ultrasound on quantitation of myocardial perfusion |
| Q30441574 | Effect of microbubble ligation to cells on ultrasound signal enhancement: implications for targeted imaging |
| Q57450320 | Effects of Nitroglycerin on Erythrocyte Rheology and Oxygen Unloading |
| Q86992730 | Efficacy and spatial distribution of ultrasound-mediated clot lysis in the absence of thrombolytics |
| Q49918938 | Endothelial vascular cell adhesion molecule 1 is a marker for high-risk carotid plaques and target for ultrasound molecular imaging |
| Q30470685 | Enhancement of left ventricular cavity opacification by harmonic imaging after venous injection of Albunex |
| Q38700884 | Exercise versus vasodilator stress limb perfusion imaging for the assessment of peripheral artery disease |
| Q30442068 | Factors affecting the endothelial retention of targeted microbubbles: influence of microbubble shell design and cell surface projection of the endothelial target molecule. |
| Q96347213 | Flow Augmentation in the Myocardium by Ultrasound Cavitation of Microbubbles: Role of Shear-Mediated Purinergic Signaling |
| Q50480548 | Functional adaptations of the coronary microcirculation to anaemia in fetal sheep. |
| Q30446090 | Future applications of contrast echocardiography |
| Q104691497 | High-Intensity Ultrasound Catheter Ablation Achieves Deep, Mid-Myocardial Lesions In-Vivo |
| Q51073080 | High-resolution myocardial perfusion imaging in mice with high-frequency echocardiographic detection of a depot contrast agent. |
| Q44879284 | Imaging of Myocardial Perfusion with SonoVuetrade mark in Patients with a Prior Myocardial Infarction |
| Q82883790 | Imaging the forgotten chamber: is the devil in the boundary? |
| Q30310994 | Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. |
| Q30438627 | Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting |
| Q30433799 | Incremental value of cardiac imaging in patients presenting to the emergency department with chest pain and without ST-segment elevation: a multicenter study |
| Q45854891 | Influence of DNA-Microbubble Coupling on Contrast Ultrasound-Mediated Gene Transfection in Muscle and Liver. |
| Q30310184 | Influence of microbubble shell properties on ultrasound signal: Implications for low-power perfusion imaging |
| Q30309873 | Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement |
| Q30471523 | Insights into the assessment of myocardial perfusion offered by different cardiac imaging modalities |
| Q30470360 | Interactions between microbubbles and ultrasound: in vitro and in vivo observations |
| Q30407883 | Ischemic memory imaging in nonhuman primates with echocardiographic molecular imaging of selectin expression |
| Q92997593 | Limb Perfusion During Exercise Assessed by Contrast Ultrasound Varies According to Symptom Severity in Patients with Peripheral Artery Disease |
| Q30439764 | Limb stress-rest perfusion imaging with contrast ultrasound for the assessment of peripheral arterial disease severity |
| Q89125738 | Lipoprotein Apheresis Acutely Reverses Coronary Microvascular Dysfunction in Patients With Severe Hypercholesterolemia |
| Q30304696 | Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes |
| Q100944489 | Microbubble-Facilitated Ultrasound Catheter Ablation Causes Microvascular Damage and Fibrosis |
| Q38308308 | Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours |
| Q30433669 | Microbubbles in medical imaging: current applications and future directions |
| Q40033319 | Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis. |
| Q30433625 | Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo |
| Q30309358 | Microvascular rheology of Definity microbubbles after intra-arterial and intravenous administration |
| Q44919955 | Mixed meal and light exercise each recruit muscle capillaries in healthy humans |
| Q30471235 | Modeling the myocardial dilution curve of a pure intravascular indicator |
| Q30473382 | Molecular Imaging of Activated von Willebrand Factor to Detect High-Risk Atherosclerotic Phenotype |
| Q90667459 | Molecular Imaging of VWF (von Willebrand Factor) and Platelet Adhesion in Postischemic Impaired Microvascular Reflow |
| Q30489494 | Molecular imaging of endothelial progenitor cell engraftment using contrast-enhanced ultrasound and targeted microbubbles |
| Q47680752 | Molecular imaging of endothelial vascular cell adhesion molecule-1 expression and inflammatory cell recruitment during vasculogenesis and ischemia-mediated arteriogenesis |
| Q36617730 | Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. |
| Q50970470 | Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. |
| Q30492960 | Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease |
| Q30443135 | Molecular imaging of the paracrine proangiogenic effects of progenitor cell therapy in limb ischemia |
| Q37466636 | Molecular imaging reveals rapid reduction of endothelial activation in early atherosclerosis with apocynin independent of antioxidative properties |
| Q30312262 | Molecular imaging with contrast ultrasound and targeted microbubbles |
| Q30438207 | Multimodality cardiovascular molecular imaging, Part II |
| Q91111421 | Myocardial Infarction Produces Sustained Proinflammatory Endothelial Activation in Remote Arteries |
| Q30308621 | Myocardial and microcirculatory kinetics of BR14, a novel third-generation intravenous ultrasound contrast agent |
| Q30433849 | Myocardial contrast echocardiography |
| Q30469909 | Myocardial contrast echocardiography in acute myocardial infarction using aortic root injections of microbubbles in conjunction with harmonic imaging: potential application in the cardiac catheterization laboratory |
| Q30471759 | Myocardial perfusion characteristics and hemodynamic profile of MRX-115, a venous echocardiographic contrast agent, during acute myocardial infarction |
| Q30470885 | Myocardial perfusion imaging in the setting of coronary artery stenosis and acute myocardial infarction using venous injection of a second-generation echocardiographic contrast agent |
| Q37167820 | Myocardial perfusion imaging with contrast echocardiography |
| Q30310466 | Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins |
| Q30305905 | Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles |
| Q30309235 | Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography |
| Q30308268 | Noninvasive prediction of ultimate infarct size at the time of acute coronary occlusion based on the extent and magnitude of collateral-derived myocardial blood flow |
| Q30306464 | Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes |
| Q30440314 | Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle |
| Q28353954 | Optical and acoustical dynamics of microbubble contrast agents inside neutrophils |
| Q89754479 | Perfusion controls muscle glucose uptake by altering the rate of glucose dispersion in vivo |
| Q30308296 | Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment |
| Q80092184 | Placing faith in numbers: quantification of perfusion with myocardial contrast echocardiography |
| Q98881123 | Ponatinib coronary microangiopathy: novel bedside diagnostic approach and management with N-acetylcysteine |
| Q37540095 | Proinflammatory endothelial activation detected by molecular imaging in obese nonhuman primates coincides with onset of insulin resistance and progressively increases with duration of insulin resistance |
| Q101217974 | Proteolysis of Von Willebrand Factor Influences Inflammatory Endothelial Activation and Vascular Compliance in Atherosclerosis |
| Q35130776 | Quantification of residual limb skeletal muscle perfusion with contrast-enhanced ultrasound during application of a focal junctional tourniquet |
| Q86925733 | Real-time contrast ultrasound muscle perfusion imaging with intermediate-power imaging coupled with acoustically durable microbubbles |
| Q96301543 | Regional and Conducted Vascular Effects of Endovascular Ultrasound Catheters |
| Q30309902 | Relation between myocardial oxygen consumption and myocardial blood volume: a study using myocardial contrast echocardiography |
| Q30424128 | Renal retention of lipid microbubbles: a potential mechanism for flank discomfort during ultrasound contrast administration |
| Q47958985 | Rest-Stress Limb Perfusion Imaging in Humans with Contrast Ultrasound Using Intermediate-Power Imaging and Microbubbles Resistant to Inertial Cavitation |
| Q92396778 | Seeing the Invisible-Ultrasound Molecular Imaging |
| Q30436934 | Simultaneous integrin alphavbeta3 and glycoprotein IIb/IIIa inhibition causes reduction in infarct size in a model of acute coronary thrombosis and primary angioplasty |
| Q42514544 | Skeletal and myocardial microvascular blood flow in hydroxycarbamide-treated patients with sickle cell disease. |
| Q30444650 | Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition |
| Q30309265 | Skin perfusion assessed by contrast ultrasound predicts tissue survival in a free flap model |
| Q30312032 | Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles |
| Q30442452 | Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow |
| Q44190009 | Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi |
| Q30439177 | Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn's disease |
| Q42198780 | Temporal Changes in Skeletal Muscle Capillary Responses and Endothelial-Derived Vasodilators in Obesity-Related Insulin Resistance |
| Q30467931 | Temporal characterization of the functional density of the vasa vasorum by contrast-enhanced ultrasonography maximum intensity projection imaging |
| Q84399181 | The umbilical cord: an ally in targeted imaging research? |
| Q30312289 | The vasodilatory actions of insulin on resistance and terminal arterioles and their impact on muscle glucose uptake |
| Q92568233 | Therapeutic Contrast Echocardiography: Bubbles Become Medicine |
| Q50675944 | Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle. |
| Q91258067 | Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib |
| Q92243194 | Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events: From Mechanism to Patient Care |
| Q88083584 | Ultrasound Molecular Imaging of Atherosclerosis Using Small-Peptide Targeting Ligands Against Endothelial Markers of Inflammation and Oxidative Stress |
| Q92465647 | Ultrasound Molecular Imaging: Principles and Applications in Cardiovascular Medicine |
| Q30308172 | Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin |
| Q89706634 | Ultrasound molecular imaging: insights into cardiovascular pathology |
| Q30416117 | Ultrasound-mediated vascular gene transfection by cavitation of endothelial-targeted cationic microbubbles |
| Q45886981 | Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice |
| Q34994515 | Vascular gene transfer of SDF-1 promotes endothelial progenitor cell engraftment and enhances angiogenesis in ischemic muscle |
| Q30308648 | Vascular recruitment in skeletal muscle during exercise and hyperinsulinemia assessed by contrast ultrasound |
| Q47972217 | Visualizing coronary atherosclerosis in vivo: thinking big, imaging small |
| Q112858373 | Novel applications for contrast ultrasound : the development of microbubble agents for site-targeted imaging and gene delivery | thesis committee member | P9161 |
Search more.